Irritable bowel syndrome K58.9; F45.32
Synonym(s)
Definition
This section has been translated automatically.
Irritable bowel syndrome refers to a frequently occurring but not clearly defined clinical picture characterised by various abdominal complaints. It is often associated with psychosomatic diseases.
According to the S3 guideline "Irritable bowel syndrome", 3 criteria must be met:
- Complaints lasting for >3 months (e.g. abdominal pain, flatulence), which are related to the abdomen by the patient and doctor and are usually accompanied by changes in bowel movements.
- Relevant limitations of the quality of life
- There are no changes typical for other clinical pictures which are responsible for these symptoms.
Classification
This section has been translated automatically.
Irritable bowel syndrome can be divided into 3 subtypes:
- Diarrhea (IBS-D)
- Constipation (IBS-C)
- Mixed type (IBS-M)
You might also be interested in
Occurrence/Epidemiology
This section has been translated automatically.
Irritable bowel syndrome affects 7-21% of the general population at some point in their lives (Soares RL 2014).
w:m=2:1
Etiopathogenesis
This section has been translated automatically.
Irritable bowel syndrome is caused by increased intestinal sensitivity and dysfunction of the autonomic nervous system in the intestinal region (the “gut brain”); see also the gut-brain axis.
The most significant causes of irritable bowel syndrome are:
stress and anxiety, food allergies or intolerances, hyperactivity of the enteric nervous system, intestinal infections, intestinal motility disorders, disturbances in the gut flora (see gut microbiome, dysbiosis), suppression of the gut’s own immune system, microinflammation, as well as a genetic predisposition, increased serotonin release, and, in some cases, hormonal influences.
Clinic
This section has been translated automatically.
The clinical picture of irritable bowel syndrome is characterized by cramping, burning or stabbing abdominal pain. In addition, there is a feeling of pressure in the lower abdomen or left colon, bloating, audible bowel sounds, constipation, flatulence, and diarrhea. Weight loss is usually not seen.
Depending on the symptoms in the foreground, a distinction is made between a diarrhea-dominant IBS and an obstipation-dominant IBS, whereby these can also alternate in phases.
Laboratory
This section has been translated automatically.
In the case of irritable bowel syndrome, the following parameters should be within the normal range: BSG, CRP, liver and pancreatic enzymes, blood count, haemoccult test and calprotectin in the stool. Furthermore, the defecation should not contain any worm eggs.
Diagnosis
This section has been translated automatically.
For the diagnosis of irritable bowel syndrome, a medical history including clinical picture according to ROM III consensus criteria is taken. In addition, a sonography of the abdomen, a digital palpation of the colon and, if necessary, further diagnostics of the abdomen are performed.
Differential diagnosis
This section has been translated automatically.
If you are experiencing pain in the lower left abdomen, you should:
- Diverticulitis
- Inguinal hernia
- Adnexal diseases
- Endometriosis
- other colon diseases, colitis of various origins, including ulcerative colitis—
should be ruled out. In cases of pain in the left upper abdomen, diseases of the spleen, pancreas, heart, stomach, and esophagus should be ruled out.
In addition, fructose and lactose intolerance, microscopic colitis, and celiac disease should be ruled out. The same applies to food allergies and intolerances, pancreatic diseases, medications that may trigger symptoms, and intra-abdominal adhesions.
Therapy
This section has been translated automatically.
There is no known treatment for irritable bowel syndrome that has been proven effective in the long term. Treatment focuses on dietary measures and managing stress.
Dietary measures: Numerous studies confirm the positive effects of the low-FODMAP diet. In any case, avoid foods that exacerbate symptoms and eat smaller, more frequent meals. For irritable bowel syndrome, a high-fiber diet with adequate fluid intake is recommended.
In larger studies, probiotics have proven to be a helpful therapeutic option (Didari T et al. 2015).
Symptomatic treatment approaches: For cramping pain—antispasmodics. For heartburn, nausea, and constipation — prokinetics. For diarrhea —antidiarrheals.
See also the section on Internal Phytotherapy, Guidelines and Recommendations.
Naturopathy
This section has been translated automatically.
See also the section on Internal Phytotherapy —Guideline Recommendations.
Symptom-oriented: For pain, e.g., preparations containing peppermint oil, such asMedacalm®; for constipation, e.g., psyllium husks,Laxatan® M; for diarrhea, e.g., Myrrhinil Intest®.
Lifestyle therapy: Avoid trigger foods, e.g., lactose, foods containing histamine or those that release histamine; if necessary, use Lactase tablets orDaosin® for histamine intolerance. Herbal antidepressants such as lavender oil, valerian, and hops; caraway and fennel oil for predominant bloating. See alsothe low-FODMAP diet.
Research suggests that ancient grains are better tolerated and that modern soft wheat should be avoided; see also spelt, einkorn, emmer, kamut, millet, as well as pseudo-grains such as buckwheat or quinoa.
Curcumin has been shown toinhibit inflammation; it has antioxidant, spasmolytic, and antiseptic effects, as well as analgesic properties, and it lowers cholesterol levels. Studies demonstrate re-epithelialization of the intestinal mucosa. Among other effects, it leads to a reduction in TNF-alpha. It should be noted that turmeric root alone has little effect; it becomes effective only when piperine (Bio-Perine) is added. Additionally, probiotics; see also the S3 guideline on irritable bowel syndrome.
Psyllium seeds( Plantago afra seeds andPlantago ovata seeds[Indian psyllium]) and psyllium husks:Plantago ovatae seminis tegumentum
Usage: Thedaily dose of psyllium seeds or Indian psyllium seeds/psyllium husks is 10 to 30 g, or 12 to 20 g, respectively. Psyllium seeds are taken before meals. To do so, mix 1 teaspoon of the herb with approximately 150 ml of cold water and consume. Psyllium husks (1–2 teaspoons) are taken with soups or other liquids.
Preparations:Agiocur® granules,Flosine® balance granules,Mucofalk® apple/orange granules,Pascomucil® powder, Schoenenberger NatuPur,Medacalm®,Enteroplant®
Combination preparations:For irritable bowel syndrome with chronic constipation, a combination preparation containing lactulose is recommended; if diarrhea predominates, a combination preparation containing peppermint in enteric-coated capsules is recommended.
Lini semen(flaxseed)
Usage:Soaktwoto three tablespoons of ground flaxseed in ¼ to ½ liter of water, then bring to a brief boil, separate the flaxseed from the mucilage, and drink the mucilage in small sips.
Products:Linusit® Gold Premium Flaxseed, 1 packet 3 times daily before meals and 2 packets before bedtime.
Combination Preparations:Use in combination with chamomile flower extractsisrecommended; however, a ready-made combination is not available.
Menthae piperitae aetheroleum (peppermint oil)
Preparations:Chiana® enteric-coatedcapsules, 1 capsule 3 times daily before meals; Medacalm® enteric-coated hard capsules, 1 capsule 3 times daily, swallowed whole before meals
Phytotherapy internal
This section has been translated automatically.
Guideline recommendation: strongly recommended:peppermint oil (Mentha piperita) for pain and bloating. Enteric-coated capsules.
STW 5 (Iberogast) is individually recommended for symptom relief—it contains:berberine, Iberis amara, angelica root, chamomile flowers, caraway seeds, milk thistle fruit, lemon balm leaves, peppermint leaves, celandine, and licorice root. Or STW-5-II (Iberogast Advance), which has an identical composition but excludes berberine, angelica root, milk thistle fruits, and celandine.
According to the guidelines, if constipation is the primary concern, Padma Lax should be individually integrated into the treatment plan, although Padma Lax is only available through international pharmacies.
Warm caraway oil compresses are recommended.
With a positive monograph:Menthae piperitae aetheroleum,Plantaginis ovatae semen,Plantaginis ovatae seminis tegumentum,Lini semen
Without a monograph:Centellae asiaticae herba,Low-FODMAP diet
Note(s)
This section has been translated automatically.
Trade names:
Menthae piperitae aetheroleum:
Formulations: Chiana® enteric-coated capsules, 1 capsule 3 times daily before meals; Medacalm® enteric-coated hard capsules, 1 capsule 3 times daily, swallowed whole before meals; Peppermint oil AL 182 mg, enteric-coated soft capsules, 1–2 capsules 3 times daily.
Mucofalk®, Flosine® Balance, Metamucil®, as a combination preparation with senna fruit: Agiolax®
Literature
This section has been translated automatically.
- Chey WD et al. (2015) Irritable bowel syndrome: a clinical review.JAMA 313:949-958.
- Didari T et al. (2015) Effectiveness of probiotics in irritable bowel syndrome: Updated systematic review with meta-analysis. World J Gastroenterol 21:3072–3084.
- Schwille-Kiuntke J et al. (2015) Systematic review with meta-analysis: post-infectious irritable bowel syndrome following travelers’ diarrhea.Aliment Pharmacol Ther 41:1029–1037.
- Soares RL (2014) Irritable bowel syndrome: a clinical review. World J Gastroenterol. 20:12144–12160.
- Wall GC et al. (2014) Irritable bowel syndrome: a concise review of current treatment concepts. World J Gastroenterol 20:8796–8806.
- Syed K et al. (2022) Low-FODMAP Diet. September 9, 2021. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; –. PMID: 32965895.
- Magge S et al. (2012) Low-FODMAP Diet for the Treatment of Irritable Bowel Syndrome. Gastroenterol Hepatol (N Y). ;8:739–745.
- Barrett JS et al. (2010) Dietary poorly absorbed, short-chain carbohydrates increase delivery of water and fermentable substrates to the proximal colon. Aliment Pharmacol Ther 31:874–882
- Chiu HF et al. (2021) Gastroprotective Effects of Polyphenols against Various Gastrointestinal Disorders: A Mini-Review with Special Focus on Clinical Evidence. Molecules 26:2090
- DGVS, DGNM & AWMF. S3 Guideline: Definition, Pathophysiology, Diagnosis, and Treatment of Irritable Bowel Syndrome – Version: 2.3. AWMF Registry No.: 021-016. https://register.awmf.org/de/leitlinien/detail/021-016
- Ploss O. (2012) Irritable Bowel Syndrome: Naturopathy for Functional Disorders, Vol. 4. Irritable Bowel Syndrome: pp. 21–43
- Layer P et al. (2021) AWMF Registration No.: 021/016. Z Gastroenterol. 2021 Dec;59(12):1323–1415
-
Utz S et al. (2024) Which phytotherapeutics are considered in German medical guidelines for the treatment of gastroenterological diseases? Z Phytother; 45(06): 248–256. DOI: 10.1055/a-2442-2204
Incoming links (14)
Ancient grain; Campylobacter; Centellae asiaticae herba; Gut-brain axis; Kamut; Line semen; low-fodmap-diet; Menthae piperitae aetheroleum; Microbiological therapy; Phytotherapeutics; ... Show allOutgoing links (52)
Ancient grain; Angelicae radix; Berber; Buckwheat; Caraway seeds; Carvi aetheroleum; Celandine; Centellae asiaticae herba; Chamomile real; Coeliac condition; ... Show allDisclaimer
Please ask your physician for a reliable diagnosis. This website is only meant as a reference.